https://adisinsight.springer.com/trials/700033783?error=cookies_not_supported&code=bf7ec78a-df5e-45fc-a760-c9cd1fd0f187
A Phase II Pharmacokinetic and Efficacy Study of Nordihydroguaiaretic Acid (NDGA) [masoprocol] in...
This trial investigated Nordihydroguaiaretic Acid (NDGA) [masoprocol] in patients with non-metastatic recurrent prostate cancer.